Effects of Massage in Different Moments of Application on Autonomic Cardiac Modulation and Cardiorespiratory Parameters
Effects of Massage as a Recuperative Technique in Different Moments of Application on Autonomic Cardiac Modulation and Cardiorespiratory Parameters
1 other identifier
interventional
40
1 country
1
Brief Summary
Performing physical exercise alters the body's homeostasis, and recuperative techniques seek to anticipate and potentiate the body's recovery. One of the ways to demonstrate a recovery of the organism is the resumption of autonomic cardiac modulation analyzed through heart rate variability (HRV), a method of global assessment of the behavior of the autonomic nervous system. Among the recovery techniques, massage is the most widely used technique in sports. Therefore, the objective of the study will be to measure the effects of massage as a recuperative technique on autonomic cardiac modulation at different moments of application. It will be a randomized clinical trial where there will be five stages of evaluation. In the first stage, the behavior of the baseline HRV will be evaluated, in the second stage the behavior of the HRV in front of the massage, in the third stage the behavior of the HRV in front of the stress protocol, in the fourth stage the HRV behavior after the stress protocol and immediately after Execution of the massage and finally in the 5th stage where the HRV behavior will be evaluated after the stress protocol and the massage application will be performed at the moment of HRV recovery. The stress protocol will be composed of squats followed by jumps and wingate test, and massage by slides in the anterior thighs and posterior trunk. The HRC indexes in the time domain, frequency domain and Poincaré plot, as well as cardiorespiratory parameters and a questionnaire on individual touch perception will be analyzed. The descriptive statistical method will be used and comparisons of cardiorespiratory parameters and HRV indices will be performed using the analysis of variance technique for repeated measures model in the two factor scheme. The level of significance will be p \<0.05 for all tests.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy-volunteers
Started Apr 2018
Shorter than P25 for not_applicable healthy-volunteers
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2017
CompletedFirst Posted
Study publicly available on registry
March 29, 2017
CompletedStudy Start
First participant enrolled
April 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 14, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2018
CompletedMarch 12, 2018
March 1, 2018
1 month
February 21, 2017
March 8, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Heart Rate Variability (HRV) - Linear indices - Frequency domain
HRV is a noninvasive and selective way of assessing the autonomic function being determined by analyzing the time series of the RR intervals. The HRV analysis will be performed by the Polar Electro Oy - V800 cardiofrequency meter. In the analysis of the linear methods, 3 rMSSD, SDNN and pNN50 indices will be used within the time domain. RMSSD corresponds to the square root of the square mean of the differences between the adjacent normal RR intervals in a time interval expressed in milliseconds. The SDNN index represents the standard deviation of all normal RR intervals recorded over a time interval, expressed in milliseconds. And finally, the pNN50 index is the percentage of adjacent RR intervals with a duration difference greater than 50 milliseconds.
First 5 minutes of rest; During recovery 5 minutes initial; 10º to 15ºm; 20º to 25ºm; 30º to 35ºm; 40º to 45ºm; 50º to 55ºm; 60º to 65ºm; 70º to 75ºm; 90º to 95ºm; 115º to 120ºm.
Heart Rate Variability (HRV) - Linear indices - Time domain
HRV is a noninvasive and selective way of assessing the autonomic function being determined by analyzing the time series of the RR intervals. The HRV analysis will be performed by the Polar Electro Oy - V800 cardiofrequency meter. In the analysis of the linear methods, 3 LF, HF and LF / HF indices will be used within the frequency domain. Low frequency corresponds to frequencies between 0.04 and 0.15 Hz (LF - frequency between 0.04 and 0.15 Hz), high frequency (HF - frequency between 0.15 and 0.4 Hz) and the ratio between these components ( LF / HF). These indices shall be expressed in ms² and standard units.
First 5 minutes of rest; During recovery 5 minutes initial; 10º to 15ºm; 20º to 25ºm; 30º to 35ºm; 40º to 45ºm; 50º to 55ºm; 60º to 65ºm; 70º to 75ºm; 90º to 95ºm; 115º to 120ºm.
Heart Rate Variability (HRV) - Plot of Poincaré
HRV is a noninvasive and selective way of assessing the autonomic function being determined by analyzing the time series of the RR intervals. The HRV analysis will be performed by the Polar Electro Oy - V800 cardiofrequency meter. The Poincaré plot is a map of points in Cartesian coordinates constructed from the values of the RR intervals obtained, where each point is represented on the x (horizontal / abscissa) axis by the preceding normal RR interval e, on the y axis (vertical / ordinate) By the following RR interval
First 5 minutes of rest; During recovery 5 minutes initial; 10º to 15ºm; 20º to 25ºm; 30º to 35ºm; 40º to 45ºm; 50º to 55ºm; 60º to 65ºm; 70º to 75ºm; 90º to 95ºm; 115º to 120ºm.
Secondary Outcomes (3)
Heart rate.
1, 3, 5, 7, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110 and 120 minutes.
Oxygen saturation.
1, 3, 5, 7, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110 and 120 minutes.
Respiratory rate.
1, 3, 5, 7, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110 and 120 minutes.
Study Arms (5)
Control
NO INTERVENTIONOnly the HRV will be followed for two hours without intervention.
Only Massage
EXPERIMENTALOnly the massage, and will have the monitoring of the HRV on the techniques and accompanied for two hours.
Only Exercise
EXPERIMENTALOnly the exercise, and will have the monitoring of the HRV on the techniques and accompanied for two hours.
Exercise and Massage immediately
EXPERIMENTALPerforming the exercise and massage immediately after, will be accompanied by the HRV during the techniques and two hours after.
Exercise and Massage after recovery
EXPERIMENTALPerforming the exercise and massage will be applicated after recovery of HRV, will be accompanied by the HRV during the techniques and two hours afte
Interventions
Approximately 12 minutes of massage will be performed in full. The massage will be performed on the lower (anterior) and trunk (posterior)
A wingate protocol will be performed followed by 10 sets of 10 squats followed by jumps.
Eligibility Criteria
You may qualify if:
- Healthy Volunteers
- Appropriate age limit
- Male
You may not qualify if:
- Smokers
- Use of drugs that influence the autonomic modulation of the heart.
- Ethicalists
- Carriers of known metabolic and / or endocrine disorders
- Sedentary individuals, insufficiently active and very active according to IPAQ
- Individuals outside the BMI range
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nilton Mantovani Junior
Presidente Prudente, São Paulo, 19025-833, Brazil
Related Publications (1)
Mantovani Junior N, Pizzo Junior E, Dos Santos Siqueira M, de Souza Cavina AP, Pastre CM, Marques Vanderlei F. Effects of massage as a recuperative technique on autonomic modulation of heart rate and cardiorespiratory parameters: a study protocol for a randomized clinical trial. Trials. 2018 Aug 25;19(1):459. doi: 10.1186/s13063-018-2830-1.
PMID: 30144819DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The investigator and the assessor will not receive information about the participant, not knowing, from which group the participant has just arrived for intervention in the investigator's case and the assessor will not receive group information in the HRV data packet.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 21, 2017
First Posted
March 29, 2017
Study Start
April 9, 2018
Primary Completion
May 14, 2018
Study Completion
July 30, 2018
Last Updated
March 12, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share